When investors think about biotech stocks, the word ‘lotto’ ticket often comes to mind. Clinical researchers bank their entire existence on a single drug or compound. But that couldn’t be further from the truth! Today’s biotech sector is robust and features plenty of massive drug markers with billions in cash flows. This includes our latest Best Health Care Dividend Stocks List pick.
Our pick is one of the sector’s elder statesmen and features a huge portfolio of blockbuster drugs under its belt. With plenty of oncology, cardiac, and other therapies under its belt, our pick produces ample profits and has a cash-rich balance. Lotto ticket it is not.
The best part is it uses that balance sheet to not only reward shareholders through rising dividends, but additional research/smart M&A.
With its robust pipeline and current winners on the market, our pick makes for a top dividend name. Watch for when the stock goes ex-dividend on Monday, May 16.
You can check out the Best Health Care Dividend Stocks List to explore all the stocks.
